ALIGOS THERAPEUTICS INC shareholders Q2 2023

ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 42 filers reported holding ALIGOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

ALIGOS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,320,381$2,253,0902.67%
TANG CAPITAL MANAGEMENT LLC 3,329,048$3,232,5060.48%
Vivo Capital, LLC 3,547,030$3,444,1660.24%
Pivotal bioVenture Partners Investment Advisor LLC 743,215$721,6620.24%
Newtyn Management, LLC 900,000$873,9000.21%
SILVERARC CAPITAL MANAGEMENT, LLC 631,887$613,5620.19%
EcoR1 Capital, LLC 3,948,360$3,833,8580.09%
HHLR ADVISORS, LTD. 2,309,764$2,242,7810.05%
Baker Brothers Advisors 2,076,400$2,016,1840.01%
HARBOURVEST PARTNERS LLC 18,783$18,2380.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,223,278$1,187,8030.00%
ACADIAN ASSET MANAGEMENT LLC 564,715$5470.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 92,000$89,3320.00%
Virtu Financial LLC 18,353$180.00%
Renaissance Technologies 430,555$4180.00%
Choate Investment Advisors 24,000$23,3040.00%
BANK OF AMERICA CORP /DE/ 1,150,945$1,117,5680.00%
WELLS FARGO & COMPANY/MN 198$1920.00%
NORTHERN TRUST CORP 39,351$38,2100.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
External links

This page lists ALIGOS THERAPEUTICS INC's shareholders in Q2 2023. To view ALIGOS THERAPEUTICS INC's shareholder history, click here.